Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: Enclomiphene boosts natural testosterone production by stimulating the hypothalamic-pituitary-gonadal (HPG) axis, making it a ...

The landscape of muscle-building is being reshaped as fitness bros ditch the dangerous steroids and turn to a healthier performance enhancement option.

Objectives To investigate the potential long-term impacts of adult growth hormone deficiency (GHD). Design Observational, retrospective matched cohort. Setting UK Clinical Practice Research Datalink ...

Peptide therapy has gained popularity as a potential health and longevity booster, but experts are warning of cautions and limitations. Peptides are short chains of amino acids that act as messengers ...

RPGs Fable promises a Bethesda-like reactive fantasy world, and I think it will be enough to cover for The Elder Scrolls 6 Third Person Shooters "I think Speranza is heavily underutilized": Arc ...

Statins do not cause the majority of the conditions that have been listed in their package leaflets, including memory loss, depression, sleep disturbance, and erectile and sexual dysfunction, ...